Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Atopic Skin Conditions Linked to Higher Breast Implant Risks
December 2025
Women with eczema or other atopic skin conditions may face greater risks of implant-related problems after breast reconstruction, according to a new study led by researchers in Texas.
Read more
3 Jul 2015
Studies Confirm Regorafenib Benefit in Pre-Treated Metastatic Colorectal Cancer
BARCELONA-LUGANO, 3 July 2015 – The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated…
2 Jul 2015
Patients with Lowest BMI Have Shortest Survival in Pooled Analysis of Bevacizumab in Metastatic Colorectal Cancer
BARCELONA-LUGANO, 1 July 2015 – Patients with the lowest body mass index (BMI) had the shortest overall survival in an analysis of bevacizumab studies
18 May 2015
Are YOU at Increased Risk of Leukaemia?
INCREASED risk of acute lymphoblastic leukaemia (ALL) can be attributed to a genetic mutation in a similar manner to the BRCA1 mutation that can…
18 May 2015
Rise in Deadly Skin Cancer is by No Means Old News
SENIOR citizens in Britain are approximately seven times more likely to develop malignant melanoma than they were 40 years ago, according to new statistics.
11 May 2015
The Scottish Medicines Consortium Approves Gilead’s Zydelig® q (Idelalisib) for the Treatment of Follicular Lymphoma That Is Refractory to Two Prior Lines of Treatment in Adult Patients
Foster City, CA, 11 May 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Scottish Medicines Consortium (SMC) has approved Zydelig…
17 Apr 2015
One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-Line Treatment Before Test Results Available
Geneva, Switzerland, 17 April 2015 — Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving…
17 Apr 2015
Evidence Grows That Melanoma Drugs Benefit Some Lung Cancer Patients
Geneva, Switzerland, 17 April 2015 — A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to…
17 Apr 2015
New Real-World Clinical Practice Study Highlights the Value of the Oncotype DX® Breast Cancer Test for Patients, Physicians and the Health Care System
Studies present results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost-savings when the test is used in early stage breast cancer.
Loading posts...
« Previous
1
…
53
54
55
56
57
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View